HSD17B12 Antikörper (AA 40-181) (HRP)
-
- Target Alle HSD17B12 Antikörper anzeigen
- HSD17B12 (Hydroxysteroid (17-Beta) Dehydrogenase 12 (HSD17B12))
-
Bindungsspezifität
- AA 40-181
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HSD17B12 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Very-long-chain 3-oxoacyl-CoA reductase protein (40-181AA)
- Isotyp
- IgG
- Top Product
- Discover our top product HSD17B12 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- HSD17B12 (Hydroxysteroid (17-Beta) Dehydrogenase 12 (HSD17B12))
- Andere Bezeichnung
- HSD17B12 (HSD17B12 Produkte)
- Synonyme
- KAR antikoerper, SDR12C1 antikoerper, 2610510O05Rik antikoerper, AI172963 antikoerper, KIK-I antikoerper, Kik1 antikoerper, HSD17B12 antikoerper, kar antikoerper, sdr12c1 antikoerper, 17-beta-HSD 12-A antikoerper, fi06g11 antikoerper, wu:fi06g11 antikoerper, zf3.1 antikoerper, zfHSD17B12A antikoerper, zgc:55589 antikoerper, zgc:77599 antikoerper, hydroxysteroid 17-beta dehydrogenase 12 antikoerper, hydroxysteroid (17-beta) dehydrogenase 12 antikoerper, hydroxysteroid (17-beta) dehydrogenase 12 L homeolog antikoerper, hydroxysteroid (17-beta) dehydrogenase 12a antikoerper, HSD17B12 antikoerper, Hsd17b12 antikoerper, hsd17b12.L antikoerper, hsd17b12a antikoerper
- Hintergrund
-
Background: Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate to the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation.
Aliases: 12,3-ketoacyl-CoA reductase,short chain antibody, 17 beta HSD 12 antibody, 17 beta hydroxysteroid dehydrogenase 12 antibody, 17-@beta-HSD XII antibody, 17-@beta-hydroxysteroid dehydrogenase XII antibody, 17-beta-HSD 12 antibody, 17-beta-hydroxysteroid dehydrogenase 12 antibody, 17beta HSD type 12 antibody, 3 ketoacyl CoA reductase antibody, 3-ketoacyl-CoA reductase antibody, DHB12_HUMAN antibody, Estradiol 17 beta dehydrogenase 12 antibody, Estradiol 17-beta-dehydrogenase 12 antibody, HSD17B12 antibody, Hydroxysteroid (17-beta) dehydrogenase 12 antibody, KAR antibody, KIK-I antibody, Kik1 antibody, SDR12C1 antibody, Short chain dehydrogenase/reductase family 12C member 1 antibody, Steroid dehydrogenase homolog antibody
- UniProt
- Q53GQ0
- Pathways
- Steroid Hormone Biosynthesis
-